AUA Summit - Combination Immunotherapy for Kidney Cancer with Dr. Phillip Pierorazio

Advertisement

Centro de recursos Patient Magazine Podcast Donate

Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Combination Immunotherapy for Kidney Cancer with Dr. Phillip Pierorazio

Phillip Pierorazio, MD, joins the Urology Care Podcast this week to discuss Combination Immunotherapy for Kidney Cancer. Dr. Pierorazio is an Associate Professor of Urology and Oncology in the Brady Urological Institute at Johns Hopkins University in Baltimore, Md.

Immunotherapy is a strong type of care that works with our immune systems. This type of care reaches cancer cells that have spread in the body and stop them from growing. Combination Immunotherapy helps the body's immune cells (T cells) attack more cancer cells than with one drug alone.

Learn more on today's episode of the Urology Care Podcast, and by reading our new Combination Immunotherapy for Kidney Cancer fact sheet and poster.



Explore Further

Share Your Story

Have a story to share? The Urology Care Foundation invites you to share your experience with a urologic condition and how it has affected you or your family.

Make a Differnece

Your tax-deductible gift will help support the millions of patients who are faced with urologic disease. Together, we care.